New Key Statistics Module, Z-Score and F-Score
OTCPK:SFOSF Key Ratios
Market Cap $ M | 7,941.49 |
Enterprise Value $ M | 10,695.67 |
P/E(ttm) | 32.14 |
PE Ratio without NRI | 26.28 |
Forward PE Ratio | -- |
Price/Book | 1.37 |
Price/Sales | 1.58 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.46 |
Revenue (TTM) $ M | 5,653.00 |
EPS (TTM) $ | 0.10 |
Beneish M-Score | -2.57 |
10-y EBITDA Growth Rate % | 8.20 |
5-y EBITDA Growth Rate % | 4.30 |
y-y EBITDA Growth Rate % | -31.00 |
EV-to-EBIT | 18.01 |
EV-to-EBITDA | 18.01 |
PEG | 6.11 |
Shares Outstanding M | 2,672.40 |
Net Margin (%) | 4.94 |
Operating Margin % | 3.60 |
Pre-tax Margin (%) | 7.12 |
Quick Ratio | 0.79 |
Current Ratio | 1.01 |
ROA % (ttm) | 1.80 |
ROE % (ttm) | 4.39 |
ROIC % (ttm) | 1.33 |
Dividend Yield % | 3.46 |
Altman Z-Score | 1.41 |
SFOSF Number of Guru Trades
SFOSF Volume of Guru Trades
Gurus Latest Trades with OTCPK:SFOSF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:SFOSF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Shanghai Fosun Pharmaceutical (Group) Co Ltd Insider Transactions
No Available Data
News about OTCPK:SFOSF
Total 0- 1